Company: CI
Filing Date: 2025-05-02
Form Type: 10-Q
Source: 0001739940-25-000021
Chunk: 77

Company: Cigna Group
Filing Date: 2025-05-02
Form: 10-Q
Item: Part I, Item 8
Chunk 77
---
 31, 2025, the Company recognized a gain of $37 million pre-tax ($112 million after-tax) within Gain (loss) on sale of businesses in the Consolidated Statements of Income. The Company received $4.2 billion cash proceeds at closing. We expect receipt of the remaining $0.6 billion in the fourth quarter of 2025 upon HCSC's collection of amounts due from the Centers for Medicare and Medicaid Services.

The Company determined that the Disposal Group met the criteria to be classified as held for sale and aggregated and classified the assets and liabilities as held for sale in our Consolidated Balance Sheets as of December 31, 2024. The assets and liabilities held for sale as of December 31, 2024 were as follows:(In millions)December 31, 2024Cash and cash equivalents$1,339 Investments1,444 Accounts receivable, net1,927 Other assets, including Goodwill (1)2,294 Total assets of businesses held for sale7,004 Insurance and contractholder liabilities1,579 All other liabilities831 Total liabilities of businesses held for sale$2,410 (1) Includes Goodwill of $94 million as of December 31, 2024.

Integration and Transaction-Related CostsIn 2025 and 2024, the Company incurred transaction-related costs associated with the HCSC transaction. These costs incurred consisted primarily of certain projects to separate the Company's systems, products and services; fees for legal, advisory and other professional services; and certain employment-related costs. These costs were $216 million pre-tax ($164 million after-tax) for the three months ended March 31, 2025, compared with $37 million pre-tax ($29 million after-tax) for the three months ended March 31, 2024.

Note 6 – Earnings Per Share

Basic and diluted earnings per share were computed as follows:

Three Months EndedMarch 31, 2025March 31, 2024(Shares in thousands, dollars in millions, except per share amounts)BasicEffect ofDilutionDilutedBasicEffect ofDilutionDilutedShareholders' net income (loss)$1,323 $1,323 $(277)$(277)Shares:Weighted average270,867 270,867 286,465 286,465 Common stock equivalents2,086 2,086 — — Total shares270,867 2